These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effect of rosiglitazone on insulin resistance, growth factors, and reproductive disturbances in women with polycystic ovary syndrome. Belli SH; Graffigna MN; Oneto A; Otero P; Schurman L; Levalle OA Fertil Steril; 2004 Mar; 81(3):624-9. PubMed ID: 15037412 [TBL] [Abstract][Full Text] [Related]
6. Polycystic ovary syndrome and type 2 diabetes mellitus. De Leo V; Musacchio MC; Morgante G; La Marca A; Petraglia F Minerva Ginecol; 2004 Feb; 56(1):53-62. PubMed ID: 14973410 [TBL] [Abstract][Full Text] [Related]
7. Type 2 diabetes and the polycystic ovary syndrome. Pelusi B; Gambineri A; Pasquali R Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409 [TBL] [Abstract][Full Text] [Related]
8. [Ovarian insulin resistance and insulin sensitizer effect on polycystic ovary syndrome]. Wu XK; Risto E Zhonghua Fu Chan Ke Za Zhi; 2004 Dec; 39(12):804-8. PubMed ID: 15733404 [TBL] [Abstract][Full Text] [Related]
11. Ovarian function and obesity--interrelationship, impact on women's reproductive lifespan and treatment options. Rachoń D; Teede H Mol Cell Endocrinol; 2010 Mar; 316(2):172-9. PubMed ID: 19818376 [TBL] [Abstract][Full Text] [Related]
12. Polycystic ovary syndrome: evolution of a concept. Ruutiainen K; Seppälä M Curr Opin Obstet Gynecol; 1991 Jun; 3(3):326-35. PubMed ID: 1813001 [TBL] [Abstract][Full Text] [Related]
13. [Resistance to insulin and polycystic ovary syndrome]. Ducluzeau PH; Laville M; Vidal H; Pugeat M Diabetes Metab; 2001 Sep; 27(4 Pt 2):S7-12. PubMed ID: 11787441 [No Abstract] [Full Text] [Related]
14. Insulin resistance, insulin sensitization and inflammation in polycystic ovarian syndrome. Dhindsa G; Bhatia R; Dhindsa M; Bhatia V J Postgrad Med; 2004; 50(2):140-4. PubMed ID: 15235215 [TBL] [Abstract][Full Text] [Related]
15. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes? Corbould A Panminerva Med; 2008 Dec; 50(4):279-94. PubMed ID: 19078869 [TBL] [Abstract][Full Text] [Related]
16. [Early metabolic abnormalities--insulin resistance, hyperinsulinemia, impaired glucose tolerance and diabetes, in adolescent girls with polycystic ovarian syndrome]. Otto-Buczkowska E; Jarosz-Chobot P; Deja G Przegl Lek; 2006; 63(4):234-8. PubMed ID: 17080748 [TBL] [Abstract][Full Text] [Related]
17. The management of insulin resistance in polycystic ovary syndrome. Teede HJ; Hutchison SK; Zoungas S Trends Endocrinol Metab; 2007 Sep; 18(7):273-9. PubMed ID: 17698366 [TBL] [Abstract][Full Text] [Related]
18. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Legro RS; Castracane VD; Kauffman RP Obstet Gynecol Surv; 2004 Feb; 59(2):141-54. PubMed ID: 14752302 [TBL] [Abstract][Full Text] [Related]
19. Growth hormone insufficiency and its impact on ovarian function. Spiliotis BE Ann N Y Acad Sci; 2003 Nov; 997():77-84. PubMed ID: 14644812 [TBL] [Abstract][Full Text] [Related]